[ SITAGLOW-M 50/100 ]
Sitagliptin + Metformin Tablets
Composition:
Each Tablet Contains:
Sitagliptin 50 mg
Metformin 100 mg
Storage:
Store in a cool, dry & dark place below 25°C
Share Your Product:
Product Description
SITAGLOW-M 50/100 is a balanced combination therapy designed for early and effective management of Type-2 Diabetes. It is suitable for patients who need additional glycemic control beyond monotherapy.
With its dual mechanism of action, it helps control blood glucose levels while preserving beta-cell function, ensuring safe and long-term diabetes care.
Uses of SITAGLOW-M 50/100
- Type-2 Diabetes Mellitus
- Early combination therapy
- HbA1c > 7.5% patients
- Metformin-failure patients
Benefits of SITAGLOW-M 50/100
Balanced Glycemic Control
- Controls both fasting (FPG) and postprandial glucose (PPG)
- Helps reduce HbA1c effectively
- Suitable for early-stage combination therapy
Dual Mechanism Action
- Improves insulin secretion (glucose-dependent)
- Reduces hepatic glucose production
- Preserves beta-cell function
Patient-Friendly Therapy
- Weight neutral
- Lower risk of hypoglycaemia
- Safe for long-term use
How SITAGLOW-M 50/100 Works
Sitagliptin (DPP-4 Inhibitor):
Enhances incretin hormones to improve insulin response.
Metformin:
Reduces glucose production and improves insulin sensitivity.
How to Use
Take this medicine as prescribed by your doctor. Usually taken with meals.
Safety Information
- Alcohol
Avoid alcohol. - Pregnancy
Consult your doctor. - Breastfeeding
Use only if prescribed. - Driving
Generally safe. - Kidney
Use with caution. - Liver
Consult your doctor.